Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease-Reference-Cited by-同舟云学术

Validated international definition of the thrombocytopenia, anasarca, fever, reticulin fibrosis, renal insufficiency, and organomegaly clinical subtype (TAFRO) of idiopathic multicentric Castleman disease

Published:2021-07-28 Issue:10 Volume:96 Page:1241-1252
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am J Hematol

Author:

Nishimura Yoshito¹²^ORCID,Fajgenbaum David C.³^ORCID,Pierson Sheila K.³^ORCID,Iwaki Noriko⁴,Nishikori Asami⁵,Kawano Mitsuhiro⁶,Nakamura Naoya⁷,Izutsu Koji⁸,Takeuchi Kengo⁹¹⁰¹¹,Nishimura Midori Filiz¹²^ORCID,Maeda Yoshinobu¹³,Otsuka Fumio¹,Yoshizaki Kazuyuki¹⁴,Oksenhendler Eric¹⁵¹⁶,Rhee Frits¹⁷^ORCID,Sato Yasuharu⁵^ORCID

Affiliation:

1. Department of General Medicine Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Okayama Japan

2. Department of Medicine John A. Burns School of Medicine, University of Hawai'i Honolulu Hawaii USA

3. Center for Cytokine Storm Treatment & Laboratory, Division of Translational Medicine and Human Genetics Perelman School of Medicine, University of Pennsylvania Philadelphia Pennsylvania USA

4. Hematology/Respiratory Medicine Kanazawa University Graduate School of Medical Science Kanazawa Japan

5. Division of Pathophysiology Okayama University Graduate School of Health Sciences Okayama Japan

6. Department of Rheumatology Kanazawa University Graduate School of Medical Science Kanazawa Japan

7. Department of Pathology Tokai University School of Medicine Isehara Japan

8. Department of Hematology National Cancer Center Hospital Tokyo Japan

9. Department of Pathology The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

10. Division of Pathology Cancer Institute, Japanese Foundation for Cancer Research Tokyo Japan

11. Pathology Project for Molecular Targets Cancer Institute, Japanese Foundation for Cancer Research Tokyo Japan

12. Department of Pathology Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Okayama Japan

13. Department of Hematology Oncology and Respiratory Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

14. Department of Organic Fine Chemicals Institute of Scientific and Industrial Research, Osaka University Osaka Japan

15. Department of Clinical Immunology Hôpital Saint‐Louis Paris France

16. Université de Paris Paris France

17. Myeloma Center University of Arkansas for Medical Sciences Little Rock Arkansas USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26292

Reference44 articles.

1. Thrombocytopenia with mild bone marrow fibrosis accompanied by fever, pleural effusion, ascites and hepatosplenomegaly;Takai K;Rinsho Ketsueki.,2010

2. Atypical Hyaline Vascular-Type Castleman's Disease With Thrombocytopenia, Anasarca, Fever, and Systemic Lymphadenopathy

3. Japanese Variant of Multicentric Castleman's Disease Associated With Serositis and Thrombocytopenia ^|^mdash; A Report of Two Cases: Is TAFRO Syndrome (Castleman- Kojima Disease) a Distinct Clinicopathological Entity?

4. Castleman–Kojima disease (TAFRO syndrome) in a Caucasian patient: A rare case report and review of the literature

5. A life-threatening case of TAFRO syndrome with dramatic response to tocilizumab, rituximab, and pulse steroids

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dysmorphic megakaryocytes in TAFRO syndrome: A case series from a single institute;Blood Cells, Molecules, and Diseases;2024-09

2. Idiopathic multicentric Castleman disease-TAFRO after COVID-19: A case report;Modern Rheumatology Case Reports;2024-08-23

3. TAFRO syndrome with abdominal pain as the first symptom accompanied by liver damage with hyperbilirubinemia: A case report;Heliyon;2024-08

4. Increase in Vascular Endothelial Growth Factor (VEGF) Expression and the Pathogenesis of iMCD-TAFRO;Biomedicines;2024-06-14

5. A case of TAFRO syndrome after vaccination, successfully treated with cyclosporine;BMC Nephrology;2024-06-13